By affecting the metabolism of arachidonic acid, shikimic acid inhibits platelet aggregation, thereby inhibiting the formation of arterial, venous thrombosis and cerebral thrombosis, and has anti-inflammatory and analgesic effects. It can also be used as an intermediate of antiviral drugs and anticancer drugs. This product is irritating and should not be used directly.
Shikimic acid is a key metabolic intermediate in the biosynthesis of aromatic amino acids. The primary industrial route involves extraction from Ilex chinensis or microbial fermentation. Its molecular formula is C7H10O5, and the CAS number is 138-59-0.
Storage requires sealed containers in cool, dry conditions below 25°C to prevent degradation. Industrial handling mandates PPE including gloves and goggles; avoid inhalation of dust. Clinical use is restricted to pharmaceutical-grade intermediates only, not direct human consumption.